Clinical Trial Update: Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating adipose-derived stem cells for ischemic congestive heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Failure

Drugs mentioned

• Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Ischemic Congestive Heart Failure | Phase 1 | Status: WITHDRAWN